{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:00:05Z","timestamp":1781632805373,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Econ Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are three common and significant causes of lymphadenopathy (LAP) in tuberculosis-and-HIV-endemic settings - tuberculosis, lymphoma, and metastatic solid organ cancers. Overlapping clinical symptoms of these diseases necessitates diagnostic procedural investigation. Fine needle aspiration (FNA) with Xpert TB\/RIF Ultra has good sensitivity for tuberculosis diagnosis, while FNA cytology can detect solid cancer lymph node metastasis, although with lower sensitivity. Critically, lymphoma cannot be reliably detected or classified using FNA. Lymphoma diagnosis often is made after repeat testing and eventual surgical excision biopsy (SEB), contributing to treatment delays, inappropriate empiric anti-tuberculosis therapy, and increased strain on already limited healthcare resources.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study presents a comparative provider-perspective cost analysis of three diagnostic procedures: FNA, SEB and core-needle biopsy (CNB). Costs were evaluated for individual procedures and within investigative pathways for unexplained LAP. Data were collected at Groote Schuur Hospital, a tertiary academic hospital in South Africa, during 2018 and 2025. Costing was conducted using a mixed-methods approach combining bottom-up ingredients-based costing with top-down allocation of overheads. Capital costs were annualised, and all costs were adjusted to 2025 values in United States dollars.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Histological diagnosis and tuberculosis testing using CNB were less costly (US$ 145) than either SEB (US$ 244), or FNA cytology and tuberculosis testing (US$ 179). Total investigative costs increased substantially when repeat FNAs were required while awaiting access to SEB (US$ 518). CNB demonstrated high diagnostic accuracy and obviated the need for further procedures in most cases, improving diagnostic efficiency and offering significant potential for cost savings. Sensitivity analyses suggested further reductions in CNB costs are possible through task-shifting to junior clinicians and through the use of reusable biopsy equipment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The CNB-centred diagnostic approach to lymphadenopathy provides lower-cost, timeous, and accurate diagnosis of the three most significant causes of LAP in tuberculosis- and HIV-endemic settings. This approach enables early initiation of appropriate treatment, reduces unnecessary procedures, and optimises the use of limited healthcare resources. These findings support the integration of CNB into national diagnostic algorithms and highlight the value of investments in training and equipment to enable its decentralised implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13561-026-00715-1","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:25:59Z","timestamp":1770387959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Point-of-care core needle biopsy pathway for early diagnosis of lymph node masses: comparative costing of a scalable pathway"],"prefix":"10.1186","volume":"16","author":[{"given":"David","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waarisa","family":"Fareed-Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Antel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karryn","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Verburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Cunnama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"6","key":"715_CR1","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"715_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/QAD.0b013e3283437f77","volume":"25","author":"CJ Achenbach","year":"2011","unstructured":"Achenbach CJ, Cole SR, Kitahata MM, Casper C, Willig JH, Mugavero MJ, et al. Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy. AIDS. 2011;25(5):691\u2013700.","journal-title":"AIDS"},{"issue":"5","key":"715_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/596766","volume":"48","author":"F Bonnet","year":"2009","unstructured":"Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, et al. Changes in cancer mortality among Hiv-infected patients: the Mortalit\u00e9 2005 survey. Clin Infect Dis. 2009;48(5):633\u20139.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"715_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJMra1615896","volume":"378","author":"R Yarchoan","year":"2018","unstructured":"Yarchoan R, Uldrick TS. Hiv-associated cancers and related diseases. N Engl J Med. 2018;378(11):1029\u201341.","journal-title":"N Engl J Med"},{"issue":"1","key":"715_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-15219-0","volume":"25","author":"S Dawood","year":"2025","unstructured":"Dawood S, McMillan B, Brown K, Oosthuizen J, Richardson D, Simba K, et al. Early-stage Hodgkin lymphoma in Cape Town, South Africa: prognostic risk factors at diagnosis and treatment outcomes. BMC Cancer. 2025;25(1):1813.","journal-title":"BMC Cancer"},{"key":"715_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7196\/SAMJ.2019.v109i10.14360","volume":"109","author":"E Verburgh","year":"2019","unstructured":"Verburgh E, Antel K. Approach to lymphoma diagnosis and management in South Africa. S Afr Med J. 2019;109:715\u20138.","journal-title":"S Afr Med J"},{"issue":"20","key":"715_CR7","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"key":"715_CR8","first-page":"31","volume":"0","author":"K Thakkar","year":"2016","unstructured":"Thakkar K, Ghaisas SM, Singh M. Lymphadenopathy: differentiation between tuberculosis and other non-tuberculosis causes like follicular lymphoma. Front Public Health. 2016;0:31.","journal-title":"Front Public Health"},{"issue":"11","key":"715_CR9","first-page":"896","volume":"94","author":"HL Gaddey","year":"2016","unstructured":"Gaddey HL, Riegel AM. Unexplained lymphadenopathy: evaluation and differential diagnosis. Am Fam Physician. 2016;94(11):896\u2013903.","journal-title":"Am Fam Physician"},{"issue":"2 Suppl","key":"715_CR10","first-page":"158","volume":"39","author":"S Mohseni","year":"2014","unstructured":"Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A. Peripheral lymphadenopathy: approach and diagnostic tools. Iran J Med Sci. 2014;39(2 Suppl):158.","journal-title":"Iran J Med Sci"},{"key":"715_CR11","doi-asserted-by":"publisher","DOI":"10.7196\/samj.2019.v109i10.14361","author":"K Antel","year":"2019","unstructured":"Antel K, Verburgh E. Lymphadenopathy in a tuberculosis-endemic area: diagnostic pitfalls and suggested approach. S Afr Med J. 2019. https:\/\/doi.org\/10.7196\/samj.2019.v109i10.14361.","journal-title":"S Afr Med J"},{"key":"715_CR12","doi-asserted-by":"crossref","unstructured":"Gounden S, Perumal R, Magula NP. Extrapulmonary tuberculosis in the setting of HIV hyperendemicity at a tertiary hospital in Durban, South Africa. 2018. 2018;33(3):8.","DOI":"10.4102\/sajid.v33i3.15"},{"key":"715_CR13","unstructured":"WHO. The top 10 causes of death: World Health Organisation. 2024 updated 07\/08\/2024. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"715_CR14","volume-title":"Global tuberculosis report 2023","author":"WHO","year":"2023","unstructured":"WHO. Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"issue":"8","key":"715_CR15","doi-asserted-by":"publisher","first-page":"e0010425","DOI":"10.1128\/spectrum.00104-25","volume":"13","author":"C Guillet-Caruba","year":"2025","unstructured":"Guillet-Caruba C, B\u00e9net C, Jmel H, Doucet-Populaire F, Bourgeois-Nicolaos N. Accelerating extrapulmonary tuberculosis diagnosis with a rapid molecular assay. Microbiol Spectr. 2025;13(8):e0010425.","journal-title":"Microbiol Spectr"},{"issue":"1","key":"715_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12879-019-4749-x","volume":"20","author":"K Antel","year":"2020","unstructured":"Antel K, Oosthuizen J, Malherbe F, Louw VJ, Nicol MP, Maartens G, et al. Diagnostic accuracy of the Xpert MTB\/Rif ultra for tuberculosis adenitis. BMC Infect Dis. 2020;20(1):33.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"715_CR17","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.4102\/SAJHIVMED.v26i1.1752","volume":"26","author":"C Potelwa","year":"2025","unstructured":"Potelwa C, Gray S, Malherbe F, Kloppers C, Richardson D, Bailey J, et al. The diagnostic pathway to lymph node excision biopsy in an HIV- and tuberculosis-endemic region. South Afr J HIV Med. 2025;26(1):1752.","journal-title":"South Afr J HIV Med"},{"issue":"4","key":"715_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/QAD.0000000000003456","volume":"37","author":"K Antel","year":"2023","unstructured":"Antel K, Oosthuizen J, Brown K, Malherbe F, Loebenberg P, Seaton C, et al. Focused investigations to expedite cancer diagnosis among patients with lymphadenopathy in a tuberculosis and HIV-endemic region. AIDS. 2023;37(4):587\u201394.","journal-title":"AIDS"},{"issue":"6","key":"715_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.anorl.2016.01.013","volume":"133","author":"KH Oh","year":"2016","unstructured":"Oh KH, Woo JS, Cho JG, Baek SK, Jung KY, Kwon SY. Efficacy of ultrasound-guided core needle gun biopsy in diagnosing cervical lymphadenopathy. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2016;133(6):401\u20134.","journal-title":"European Annals of Otorhinolaryngology, Head and Neck Diseases"},{"issue":"15","key":"715_CR20","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1200\/JCO.2004.02.104","volume":"22","author":"ST Hehn","year":"2004","unstructured":"Hehn ST, Grogan TM, Miller TP. Utility of fine-needle aspiration as a diagnostic technique in lymphoma. J Clin Oncol. 2004;22(15):3046\u201352.","journal-title":"J Clin Oncol"},{"issue":"1","key":"715_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.7812\/TPP\/24.096","volume":"29","author":"JE Hoerter","year":"2025","unstructured":"Hoerter JE, Lynch AD, Folck BF, Anderson M, Kshirsagar RS, Gilde J, et al. Comparative analysis of biopsy techniques for cervical lymphoma: a retrospective cohort review. Perm J. 2025;29(1):108\u201313.","journal-title":"Perm J"},{"key":"715_CR22","doi-asserted-by":"publisher","unstructured":"Cozzolino I, Ehinger M, Calaminici M, Ronchi A, Al-Abbadi MA, Barroca H, Bode-Lesniewska B, Chhieng DF, Katz RL, Lin O, Medeiros LJ, Pitman MB, Rajwanshi A, Schmitt FC, Vielh P, Zeppa P, Cree IA, Sewell WA, Rekhi B, et.al. Field AS. The World Health Organization Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Part 1 - Lymph Node. Acta Cytol. 2025;27:1\u201316. Epub ahead of print. PMID: 40875665. https:\/\/doi.org\/10.1159\/000548199.","DOI":"10.1159\/000548199"},{"issue":"3","key":"715_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5858\/arpa.2020-0261-SA","volume":"145","author":"SH Kroft","year":"2021","unstructured":"Kroft SH, Sever CE, Bagg A, Billman B, Diefenbach C, Dorfman DM, et al. Laboratory workup of lymphoma in adults: guideline from the American society for clinical pathology and the college of American pathologists. Arch Pathol Lab Med. 2021;145(3):269\u201390.","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"715_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/fjs.fjs_104_20","volume":"54","author":"RamachandranR Pillai","year":"2021","unstructured":"Pillai Ramachandran R, Borkar PV, Bhaskaran R. Effectiveness of fine needle aspiration cytology versus excisional biopsy in cervical lymphadenopathy. Formosan J Surg. 2021;54(3):79.","journal-title":"Formosan J Surg"},{"key":"715_CR25","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ijom.2020.07.005","volume":"50","author":"T Cuenca-Jimenez","year":"2021","unstructured":"Cuenca-Jimenez T, Chia Z, Desai A, Moody A, Ramesar K, Grace R, et al. The diagnostic performance of ultrasound-guided core biopsy in the diagnosis of head and neck lymphoma: results in 226 patients. Int J Oral Maxillofac Surg. 2021;50:431\u20136.","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"2","key":"715_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/ejh.13532","volume":"106","author":"D Seviar","year":"2021","unstructured":"Seviar D, Yousuff M, Chia Z, Ramesar K, Newman J, Howlett DC. Image-guided core needle biopsy as the first\u2010line diagnostic approach in lymphoproliferative disorders\u2014a review of the current literature. Eur J Haematol. 2021;106(2):139\u201347.","journal-title":"Eur J Haematol"},{"issue":"8","key":"715_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00277-016-2704-0","volume":"95","author":"A Johl","year":"2016","unstructured":"Johl A, Lengfelder E, Hiddemann W, Klapper W. Core needle biopsies and surgical excision biopsies in the diagnosis of lymphoma\u2014experience at the Lymph Node Registry Kiel. Ann Hematol. 2016;95(8):1281\u20136.","journal-title":"Ann Hematol"},{"issue":"10","key":"715_CR28","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7196\/SAMJ.2019.v109i10.14360","volume":"109","author":"E Verburgh","year":"2019","unstructured":"Verburgh E, Antel K. Approach to lymphoma diagnosis and management in South Africa. South Afr Med J. 2019;109(10):715.","journal-title":"South Afr Med J"},{"issue":"16","key":"715_CR29","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1097\/MD.0000000000000095","volume":"93","author":"X Bosch","year":"2014","unstructured":"Bosch X, Coloma E, Donate C, Colomo L, Doti P, Jord\u00e1n A, et al. Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients. Med (Baltim). 2014;93(16):e95\u2013e.","journal-title":"Med (Baltim)"},{"key":"715_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5586-4","author":"K Antel","year":"2019","unstructured":"Antel K, Levetan C, Mohamed Z, Louw VJ, Oosthuizen J, Maartens G, et al. The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC Cancer. 2019. https:\/\/doi.org\/10.1186\/s12885-019-5586-4.","journal-title":"BMC Cancer"},{"issue":"10","key":"715_CR31","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.jval.2018.03.007","volume":"21","author":"HI Wang","year":"2018","unstructured":"Wang HI, Roman E, Crouch S, Aas E, Burton C, Patmore R, et al. A generic model for follicular lymphoma: predicting cost, life expectancy, and quality-adjusted-life-year using UK population\u2013based observational data. Value Health. 2018;21(10):1176\u201385.","journal-title":"Value Health"},{"issue":"4","key":"715_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.clinthera.2012.02.019","volume":"34","author":"EJ Soini","year":"2012","unstructured":"Soini EJ, Martikainen JA, Vihervaara V, Mustonen K, Nousiainen T. Economic evaluation of sequential treatments for follicular non-hodgkin lymphoma. Clin Ther. 2012;34(4):915-25.e2.","journal-title":"Clin Ther"},{"key":"715_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2147\/CEOR.S178649","volume":"10","author":"M Bonafede","year":"2018","unstructured":"Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, et al. Straus DJ. Real-world analysis of cost, health care resource utilization, and supportive care in hodgkin lymphoma patients with frontline failure. Clinico Economics Outcomes Res. 2018;10:629\u2013641. https:\/\/doi.org\/10.2147\/CEOR.S178649.","journal-title":"ClinicoEconomics Outcomes Res Dovepress ClinicoEconomics Outcomes Res"},{"key":"715_CR34","doi-asserted-by":"publisher","unstructured":"Papaioannou D, Rafia R, Rathbone J, Stevenson M, Buckley Woods H, Stevens J. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of technology Appraisal 110): a systematic review and economic evaluation. Health Technol Assess. 2012;16(37):1\u2013253. PMID: 23021127. https:\/\/doi.org\/10.3310\/hta16370.","DOI":"10.3310\/hta16370"},{"key":"715_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4187-y","author":"X Bosch","year":"2018","unstructured":"Bosch X, Sanclemente-Ans\u00f3 C, Escoda O, Moncl\u00fas E, Franco-Vanegas J, Moreno P, Guerra-Garc\u00eda M, Guasch N, L\u00f3pez-Soto A. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain. BMC Cancer. 2018;18(1):276. PMID: 29530002; PMCID: PMC5848556 https:\/\/doi.org\/10.1186\/s12885-018-4187-y.","journal-title":"BMC Cancer"},{"key":"715_CR36","unstructured":"Antel KR. Lymphoma: Understanding the diagnostic challenges and improving outcomes in a TBand HIV-endemic area. Faculty Health Sci, Department of Pathology, 2021. https:\/\/hdl.handle.net\/11427\/33628."},{"key":"715_CR37","unstructured":"SARS. Average Exchange Rates for a Year of Assessment South African Revenue Service Website. South African Revenue Service; 2021 [updated 3 December 2021. Available from: https:\/\/www.sars.gov.za\/wp-content\/uploads\/Legal\/Rates\/LAPD-Pub-AER-2012-02-Average-Exchange-Rates-Table-A.pdf."},{"key":"715_CR38","unstructured":"SA S. Consumer Price Index 2021 updated November. November edition:[PDF]. Available from: http:\/\/www.statssa.gov.za\/."},{"key":"715_CR39","unstructured":"Council for Scientific and Industrial Research; Department of Health Infrastructure Unit. Order of magnitude new hospital cost estimator: 2012."},{"key":"715_CR40","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2015","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UNITED KINGDOM: Oxford University Press; 2015."},{"key":"715_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-021-11314-6","author":"AG Hellebo","year":"2021","unstructured":"Hellebo AG, Zuhlke LJ, Watkins DA, Alaba O. Health system costs of rheumatic heart disease care in South Africa. BMC Public Health. 21, 1303 (2021). https:\/\/doi.org\/10.1186\/s12889-021-11314-6.","journal-title":"BMC Public Health"},{"key":"715_CR42","unstructured":"Anna Vassall SS, Kahn JG, Gomez G, Bollinger L, Marseille E, GHCC Technical Advisory Group. Ben Herzel, Willyanne decormier Plosky, Lucy Cunnama, Edina Sinanovic. In: Bautista S, editor. GHCC stakeholder Group, Kate Harris, Carol Levin. Reference Case for Estimating the Costs of Global Health Services and Interventions. Global Health Cost Consortium. 2017."},{"key":"715_CR43","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hec.3295","volume":"25","author":"L Cunnama","year":"2016","unstructured":"Cunnama L, Sinanovic E, Ramma L, Foster N, Berrie L, Stevens W, et al. Using Top-down and Bottom-up costing approaches in lmics: the case for using both to assess the incremental costs of new technologies at scale. Health Econ. 2016;25:53\u201366.","journal-title":"Health Econ"},{"key":"715_CR44","volume-title":"Admininstration and clerk salaries and grading for 2015","year":"2015","unstructured":"Health WCPDo. In: Health, WCPDo, editors. Admininstration and clerk salaries and grading for 2015. Western Cape: Western Cape Provincial Department of Health; 2015."},{"issue":"14","key":"715_CR45","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1080\/10428194.2020.1815016","volume":"61","author":"K Antel","year":"2020","unstructured":"Antel K, Louw VJ, Maartens G, Oosthuizen J, Verburgh E. Diagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics. Leuk Lymphoma. 2020;61(14):3417\u201321.","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"715_CR46","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1002\/cncr.32735","volume":"126","author":"E Birgin","year":"2020","unstructured":"Birgin E, Yang C, Hetjens S, Reissfelder C, Hohenberger P, Rahbari NN. Core needle biopsy versus incisional biopsy for differentiation of soft-tissue sarcomas: a systematic review and meta-analysis. Cancer. 2020;126(9):1917\u201328.","journal-title":"Cancer"},{"issue":"12","key":"715_CR47","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/cncy.21742","volume":"124","author":"PA VanderLaan","year":"2016","unstructured":"VanderLaan PA. Fine-needle aspiration and core needle biopsy: an update on 2 common minimally invasive tissue sampling modalities. Cancer Cytopathol. 2016;124(12):862\u201370.","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"715_CR48","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jasc.2020.05.012","volume":"9","author":"M Chambers","year":"2020","unstructured":"Chambers M, O\u2019Hern K, Kerr DA. Fine-needle aspiration biopsy for the diagnosis of bone and soft tissue lesions: a systematic review and meta-analysis. J Am Soc Cytopathol. 2020;9(5):429\u201341.","journal-title":"J Am Soc Cytopathol"},{"issue":"3","key":"715_CR49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1177\/0194599820945953","volume":"164","author":"D Ahn","year":"2021","unstructured":"Ahn D, Lee GJ, Sohn JH. Time and cost of ultrasound-guided fine-needle aspiration biopsy\/core-needle biopsy for primary laryngohypopharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2021;164(3):602\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"10","key":"715_CR50","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/QAD.0000000000003261","volume":"36","author":"SL Vogt","year":"2022","unstructured":"Vogt SL, Maloma L, Xian RR, Ambinder RF, Philip V, Patel M, et al. Significance of lymph node fine needle aspiration for the diagnosis of HIV-associated lymphoma in a low-resource setting. AIDS. 2022;36(10):1393\u20138.","journal-title":"AIDS"},{"key":"715_CR51","doi-asserted-by":"publisher","DOI":"10.1200\/jgo.18.66100","author":"B May","year":"2018","unstructured":"May B, Rossiter A, Heyworth P. Core biopsy and FNA: a comparison of diagnostic yield in lymph nodes of different ultrasound determined malignant potential. J Glob Oncol. 2018. https:\/\/doi.org\/10.1200\/jgo.18.66100.","journal-title":"J Glob Oncol"},{"key":"715_CR52","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16785","author":"M Molica","year":"2020","unstructured":"Molica M, Mazzone C, Cordone I, Pasquale A, Niscola P, Fabritiis P. SARS-CoV\u20102 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies. Br J Haematol. 2020. https:\/\/doi.org\/10.1111\/bjh.16785.","journal-title":"Br J Haematol"}],"container-title":["Health Economics Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13561-026-00715-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13561-026-00715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:40:41Z","timestamp":1781631641000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13561-026-00715-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1186\/s13561-026-00715-1","relation":{},"ISSN":["2191-1991"],"issn-type":[{"value":"2191-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Human Research Ethics Committee at the University of Cape Town approved the research (HREC reference numbers: 829\/2020 and 691\/2021). Institutional approval was obtained through the National Health Research Database (NHRD) and Groote Schuur Hospital. Prospective consent was taken for all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}